Search

Your search keyword '"Yannoukakos D"' showing total 285 results

Search Constraints

Start Over You searched for: Author "Yannoukakos D" Remove constraint Author: "Yannoukakos D"
285 results on '"Yannoukakos D"'

Search Results

1. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

2. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

5. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

8. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

9. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

10. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

11. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

12. One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene

13. BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects

14. Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections

17. PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk

20. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

21. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

22. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis

23. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

24. Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients

25. Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation

26. Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece

27. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

28. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

29. Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types

30. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

31. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

32. Pathology of BRCA1- and BRCA2-associated breast cancers: known and less known connections

33. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

34. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

35. Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair EDITORIAL COMMENT

36. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

37. Improved DNA microarray detection sensitivity through immobilization of preformed in solution streptavidin/biotinylated oligonucleotide conjugates

38. CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases

39. The incidence of GJB2 mutations in prelingual deafness in the Greek population

40. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

41. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

42. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium

43. MicroRNA related polymorphisms and breast cancer risk

44. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

47. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

48. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

49. 19p13.1 Is a triple-negative-specific breast cancer susceptibility locus

50. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: Implications for genetic screening selection criteria: A Hellenic Cooperative Oncology Group Study

Catalog

Books, media, physical & digital resources